APA (7th ed.) Citation

N, P., X, L., HC, L., FE, D., R, H., V, H., . . . E, T. (2026). Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis. European journal of haematology, 116(4), 458. https://doi.org/10.1111/ejh.70079

Chicago Style (17th ed.) Citation

N, Puig, et al. "Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis." European Journal of Haematology 116, no. 4 (2026): 458. https://doi.org/10.1111/ejh.70079.

MLA (9th ed.) Citation

N, Puig, et al. "Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis." European Journal of Haematology, vol. 116, no. 4, 2026, p. 458, https://doi.org/10.1111/ejh.70079.